208 related articles for article (PubMed ID: 34403195)
1. BAZ2A-mediated repression via H3K14ac-marked enhancers promotes prostate cancer stem cells.
Peña-Hernández R; Aprigliano R; Carina Frommel S; Pietrzak K; Steiger S; Roganowicz M; Lerra L; Bizzarro J; Santoro R
EMBO Rep; 2021 Nov; 22(11):e53014. PubMed ID: 34403195
[TBL] [Abstract][Full Text] [Related]
2. BAZ2A-RNA mediated association with TOP2A and KDM1A represses genes implicated in prostate cancer.
Roganowicz M; Bär D; Bersaglieri C; Aprigliano R; Santoro R
Life Sci Alliance; 2023 Jul; 6(7):. PubMed ID: 37184661
[TBL] [Abstract][Full Text] [Related]
3. TIP5 primes prostate luminal cells for the oncogenic transformation mediated by
Pietrzak K; Kuzyakiv R; Simon R; Bolis M; Bär D; Aprigliano R; Theurillat JP; Sauter G; Santoro R
Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3637-3647. PubMed ID: 32024754
[TBL] [Abstract][Full Text] [Related]
4. BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence.
Gu L; Frommel SC; Oakes CC; Simon R; Grupp K; Gerig CY; Bär D; Robinson MD; Baer C; Weiss M; Gu Z; Schapira M; Kuner R; Sültmann H; Provenzano M; ; Yaspo ML; Brors B; Korbel J; Schlomm T; Sauter G; Eils R; Plass C; Santoro R
Nat Genet; 2015 Jan; 47(1):22-30. PubMed ID: 25485837
[TBL] [Abstract][Full Text] [Related]
5. Sodium arsenite exposure enhances H3K14 acetylation and impairs male spermatogenesis in rat testes.
Li X; Shen K; Yuan D; Fan J; Yang Y; Tian F; Quan J; Li C; Wang J
Reprod Toxicol; 2023 Dec; 122():108474. PubMed ID: 37757915
[TBL] [Abstract][Full Text] [Related]
6. Reevaluation of bromodomain ligands targeting BAZ2A.
Cazzanelli G; Vedove AD; Parolin E; D'Agostino VG; Unzue A; Nevado C; Caflisch A; Lolli G
Protein Sci; 2023 Sep; 32(9):e4752. PubMed ID: 37574751
[TBL] [Abstract][Full Text] [Related]
7. BAZ2A safeguards genome architecture of ground-state pluripotent stem cells.
Dalcher D; Tan JY; Bersaglieri C; Peña-Hernández R; Vollenweider E; Zeyen S; Schmid MW; Bianchi V; Butz S; Roganowicz M; Kuzyakiv R; Baubec T; Marques AC; Santoro R
EMBO J; 2020 Dec; 39(23):e105606. PubMed ID: 33433018
[TBL] [Abstract][Full Text] [Related]
8. CUL4B regulates cancer stem-like traits of prostate cancer cells by targeting BMI1 via miR200b/c.
Jiao M; Qi M; Zhang F; Hu J; Feng T; Zhao M; Li X; Liu H; Teng W; Zhang J; Liu Z; Zhang L; Wu Z; Han B
Prostate; 2019 Aug; 79(11):1294-1303. PubMed ID: 31111526
[TBL] [Abstract][Full Text] [Related]
9. NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence.
Manda KR; Tripathi P; Hsi AC; Ning J; Ruzinova MB; Liapis H; Bailey M; Zhang H; Maher CA; Humphrey PA; Andriole GL; Ding L; You Z; Chen F
Oncogene; 2016 Jun; 35(25):3282-92. PubMed ID: 26477312
[TBL] [Abstract][Full Text] [Related]
10. Pan-cancer and multi-omics analyses revealed the diagnostic and prognostic value of BAZ2A in liver cancer.
Liu Y; Wang J; Guo J; Zhang Q; Wang S; Hu F; Wu J; Zhao Y; Zhang J; Yu Y; Li Y; Zhang X
Sci Rep; 2024 Mar; 14(1):5228. PubMed ID: 38433277
[TBL] [Abstract][Full Text] [Related]
11. Discovery of BAZ2A bromodomain ligands.
Spiliotopoulos D; Wamhoff EC; Lolli G; Rademacher C; Caflisch A
Eur J Med Chem; 2017 Oct; 139():564-572. PubMed ID: 28837921
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of the TAM domain of BAZ2A in binding to DNA or RNA independent of methylation status.
Chen S; Zhou M; Dong A; Loppnau P; Wang M; Min J; Liu K
J Biol Chem; 2021 Dec; 297(6):101351. PubMed ID: 34715126
[TBL] [Abstract][Full Text] [Related]
13. ZMYND8 Reads the Dual Histone Mark H3K4me1-H3K14ac to Antagonize the Expression of Metastasis-Linked Genes.
Li N; Li Y; Lv J; Zheng X; Wen H; Shen H; Zhu G; Chen TY; Dhar SS; Kan PY; Wang Z; Shiekhattar R; Shi X; Lan F; Chen K; Li W; Li H; Lee MG
Mol Cell; 2016 Aug; 63(3):470-84. PubMed ID: 27477906
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs and epithelial-mesenchymal transition in prostate cancer.
Sekhon K; Bucay N; Majid S; Dahiya R; Saini S
Oncotarget; 2016 Oct; 7(41):67597-67611. PubMed ID: 27588490
[TBL] [Abstract][Full Text] [Related]
15. Structural Analysis of Small-Molecule Binding to the BAZ2A and BAZ2B Bromodomains.
Dalle Vedove A; Spiliotopoulos D; D'Agostino VG; Marchand JR; Unzue A; Nevado C; Lolli G; Caflisch A
ChemMedChem; 2018 Jul; 13(14):1479-1487. PubMed ID: 29770599
[TBL] [Abstract][Full Text] [Related]
16. BET bromodomain-mediated interaction between ERG and BRD4 promotes prostate cancer cell invasion.
Blee AM; Liu S; Wang L; Huang H
Oncotarget; 2016 Jun; 7(25):38319-38332. PubMed ID: 27223260
[TBL] [Abstract][Full Text] [Related]
17. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis.
Lee E; Wang J; Yumoto K; Jung Y; Cackowski FC; Decker AM; Li Y; Franceschi RT; Pienta KJ; Taichman RS
Neoplasia; 2016 Sep; 18(9):553-66. PubMed ID: 27659015
[TBL] [Abstract][Full Text] [Related]
18. Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis.
Tian J; Lee SO; Liang L; Luo J; Huang CK; Li L; Niu Y; Chang C
J Biol Chem; 2012 Nov; 287(47):39954-66. PubMed ID: 23012352
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
[TBL] [Abstract][Full Text] [Related]
20. H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells.
Karmodiya K; Krebs AR; Oulad-Abdelghani M; Kimura H; Tora L
BMC Genomics; 2012 Aug; 13():424. PubMed ID: 22920947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
